XOMA Royalty Declares Quarterly Preferred Stock Dividends

Core Viewpoint - XOMA Royalty Corporation has announced cash dividends for holders of its Series A and Series B Cumulative Preferred Stock, reflecting the company's ongoing commitment to return value to its shareholders [1][2]. Group 1: Dividend Announcement - Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock will receive a cash dividend of $0.53906 per share [1]. - Holders of depositary shares representing 1/1000 of a share of the 8.375% Series B Cumulative Perpetual Preferred Stock will receive a cash dividend of $0.52344 per depositary share [2]. - The preferred dividends are scheduled to be paid on or about October 15, 2024, to holders of record as of October 3, 2024 [2]. Group 2: Company Overview - XOMA Royalty Corporation operates as a biotechnology royalty aggregator, assisting biotech companies in improving human health by acquiring future economic rights associated with therapeutic candidates and commercial assets [3]. - The company has a diverse and expanding portfolio with over 70 assets, defined as rights to receive potential future economics related to the advancement of underlying therapeutic candidates [3]. - The commercial assets in XOMA's portfolio include VABYSMO®, OJEMDA™, MIPLYFFA™, XACIATO™, IXINITY®, and DSUVIA®, while other assets are investigational compounds with no established efficacy or safety [4].